Bausch Health Companies (BHC) Times Interest Earned (2009 - 2026)
Bausch Health Companies (BHC) reported Times Interest Earned of $1.72 for Q1 2026, up 105.77% on a YoY basis from $0.84 in Q1 2025, and up 118.94% sequentially from $0.79 in Q4 2025.
Bausch Health Companies (BHC) Times Interest Earned (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of Times Interest Earned data on file, last reported at $1.72 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned rose 105.77% year-over-year to $1.72; the trailing twelve-month figure through Mar 2026 stood at -$1.06 (down 194.4% YoY), and the FY2025 full-year result was $0.7, up 3.98% from the prior year.
- Times Interest Earned rose to $1.72 in Q1 2026, from $0.79 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $1.72 in Q1 2026 to a low of -$0.62 in Q4 2022.
- A 5-year average of $0.75 and a median of $0.79 in 2025 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned plunged 157.59% in 2022 and soared 4810.49% in 2024, its largest moves.
- Tracing BHC's Times Interest Earned over 5 years: stood at -$0.62 in 2022, then soared by 261.84% to $1.0 in 2023, then surged by 66.04% to $1.66 in 2024, then sank by 52.53% to $0.79 in 2025, then surged by 118.94% to $1.72 in 2026.
- Business Quant data shows BHC's Times Interest Earned at $1.72 in Q1 2026, $0.79 in Q4 2025, and $1.5 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | 1.72 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.72 |
| Dec 31, 2025 | 0.79 |
| Sep 30, 2025 | 1.50 |
| Jun 30, 2025 | 0.19 |
| Mar 31, 2025 | 0.84 |
| Dec 31, 2024 | 1.66 |
| Sep 30, 2024 | 0.92 |
| Jun 30, 2024 | 0.73 |
| Mar 31, 2024 | 0.79 |
| Dec 31, 2023 | 1.00 |
| Sep 30, 2023 | 0.02 |
| Jun 30, 2023 | 1.29 |
| Mar 31, 2023 | 0.57 |
| Dec 31, 2022 | -0.62 |
| Sep 30, 2022 | 0.63 |
| Jun 30, 2022 | 0.24 |
| Mar 31, 2022 | 0.43 |
| Dec 31, 2021 | 1.07 |
| Sep 30, 2021 | 0.71 |
| Jun 30, 2021 | -0.40 |